BioVoice News eMag January-February 2024 | Page 71

active disease , which is symptomatic and infectious , is paramount . We recognize the critical role that collaboration between the public and private sectors plays in the Government ’ s mission of eradicating TB by 2025 .”
Meril Life Sciences inks pact with Japan Lifeline for promoting its transcatheter heart valve
Meril Life Sciences has signed an agreement with Japan ’ s leading cardiovascular medtech company , Japan Lifeline . This strategic alliance empowers Japan Lifeline exclusive rights to promote Meril ’ s transcatheter heart valve , Myval Octacor , upon PMDA approval in Japan . Myval Octacor is a balloon-expandable transcatheter heart valve implant designed for Transcatheter Aortic Valve Replacement / Implantation ( TAVR / TAVI ) procedures . It features a wide range of sizes to fit a broader patient population as compared to legacy technology . It also has a unique octagonal cell structure that improves accuracy of placement . More than 25,000 heart valves manufactured by Meril have been implanted across 75 countries with proven clinical safety , efficacy and are supported by 80 + scientific publications .

HealthTech

ACT For Health collaborates with Global Health Labs , Inc to bring private innovations to India ’ s public healthcare system
ACT , an Indian venture philanthropy organisation , and Global Health Labs , Inc . ( GH Labs ), an international nonprofit funded by Gates Ventures , have announced their collaboration to jointly identify Indian digital and medical technology innovators and support development and scale of their digital health and medical technology innovations . Inadequate infrastructure and a shortage of healthcare professionals in low-resourced areas in India are significant barriers to access to quality and affordable healthcare . The bold aim of this collaboration is to enable cutting-edge healthcare technology to traverse the divide and improve the quality of care across primary healthcare settings .
BIOVOICENEWS . COM 71